BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 8, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

VC funding in med-tech sees significant decrease in 2Q12

Aug. 22, 2012
By Omar Ford

InSightec set to begin Phase I clinical trial for ExAblate Neuro

Aug. 21, 2012
By Omar Ford

Deals roundup: VS acquires Venture catheter from St. Jude for $3 million

Aug. 20, 2012
By Omar Ford
Vascular Solutions (Minneapolis) reported that it has acquired the Venture wire control catheter, a deflectable-tip catheter used to provide guidewire directional control in challenging coronary and peripheral interventional procedures, from St. Jude Medical (St. Paul, Minnesota) for $3 million.
Read More

IL makes direct impact on Hemostasis line

Aug. 17, 2012
By Omar Ford
It's not always doom and gloom in the med-tech industry. Some med-tech companies are making significant strides, and it doesn't always revolve around garnering a significant funding or getting FDA approval on a product. Nearly two months ago, Instrumentation Laboratory (Bedford, Massachusetts) took a bold leap with its Hemostasis product line in North America, and decided to go with a new direct sales, support and service model. Previously the company had a strategic alliance cross-distribution agreement with Beckman Coulter (Brea, California) for about 20 years, which it deemed successful. The company already has a direct customer model in its critical...
Read More

NewCo On the Go: Domain Surgical takes FMwand from lab to market in 3 years

Aug. 17, 2012
By Omar Ford

Researchers develop device to short circuit seizures

Aug. 16, 2012
By Omar Ford

New imaging technique gives clearer picture of living organs

Aug. 15, 2012
By Omar Ford

FDA gives nod to Sanofi's automated injection device

Aug. 14, 2012
By Omar Ford

Toshiba gains FDA clearance for MR flexible coil system

Aug. 13, 2012
By Omar Ford
Toshiba American Medical Systems (Tustin, California) said that it has developed a flexible coil system that could improve MR exam efficiency and image quality. The firm reported earlier this week, that its 16-element MR coils has received clearance from the FDA.
Read More

Financings roundup: Exact prices underwritten public offering, hopes to get $50M

Aug. 9, 2012
By Omar Ford
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Illustration of brain and brain waves, concept of focal seizure

    Hyperexcitability may be joint problem in epilepsy, dementia

    BioWorld
    The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • In the clinic for July 6, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing